December 9, 2015
Bristol-Myers wraps up Cardioxyl buy. Dividend increase
Bristol-Myers Squibb Company has completed the previously announced planned acquisition of Cardioxyl Pharmaceuticals, Inc.
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
December 9, 2015
Novartis delivers 300M pediatric antimalarial no-profit-treatments since 2009
Novartis has reached a delivery milestone of 300 million pediatric antimalarial treatments supplied without profit since 2009, helping to reduce the disease burden for children in more than 30 malaria-endemic countries.
December 7, 2015
Open-source software that helps track embryonic development and movement of neuronal cells throughout the body of the worm available to scientists
A new, open-source software that can help track the embryonic development and movement of neuronal cells throughout the body of the worm, is now available to scientists.
December 7, 2015
Johnson Johnson buys Novira Therapeutics
Johnson & Johnson has completed the acquisition of Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing innovative therapies for curative treatment of chronic hepatitis B virus (HBV) infection.
December 4, 2015
TLipo Escultura and JAT Natural Corp recalling all Lipo Escultura
The FDA has informed that TLipo Escultura Corp. of Brooklyn, NY dba JAT Productos Naturales Corp., and JAT Natural Products…
December 4, 2015
Lilly quits developing basal insulin peglispro
Eli Lilly and Company will cease development of basal insulin peglispro (BIL), a potential treatment for type 1 and type 2 diabetes, in order to focus research and development efforts on other assets in its portfolio and pipeline.
December 4, 2015
Genomic Vision partners up with the University-Hospital Institute (IHU) Imagine
Genomic Vision – has signed a strategic partnership with the University-Hospital Institute (IHU) Imagine, the largest European genetic research and care cluster.
December 4, 2015
MaSTherCell will fabricate TxCell’s ASTrIA platform products in Europe
TxCell SA has signed a 5-year agreement with MaSTherCell, a Contract Manufacturing Organization (CMO), based in Belgium.
According to this agreement, MaSTherCell will be the exclusive manufacturer in Europe of all products from TxCell’s ASTrIA platform.
December 4, 2015
India’s Sun Pharmaceutical enters $2.5B US market with its generic version of Gleevec
Sun Pharmaceutical Industries, largest India-based generic pharmaceutical companies, has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Novartis’ Gleevec.
December 3, 2015
Anavex appoints Preclinical Operations vice president
Anavex has appointed Ulrich Elben, PhD as Vice President of Preclinical Operations, who will be responsible for the pipeline development and optimization.